Fuzheng Kang’ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial

被引：0
|
作者：
Xiao-Bing Yang
Wan-yin Wu
Shun-qin Long
Hong Deng
Zong-Qi Pan
Wen-Feng He
Yu-Shu Zhou
Gui-Ya Liao
Qiu-Ping Li
Shu-Jing Xiao
Jiao-Zhi Cai
机构：
[1] Guangdong Provincial Hospital of Traditional Chinese Medicine,Department of Oncology
来源：
Trials | / 16卷
关键词：
Non-small cell lung cancer; Chinese herbal medicine; decoction; Gefitinib; Randomized controlled trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial
    Yang, Xiao-Bing
    Wu, Wan-yin
    Long, Shun-qin
    Deng, Hong
    Pan, Zong-Qi
    He, Wen-Feng
    Zhou, Yu-Shu
    Liao, Gui-Ya
    Li, Qiu-Ping
    Xiao, Shu-Jing
    Cai, Jiao-Zhi
    TRIALS, 2015, 16
  • [2] Gefitinib plus Fuzheng Kang'ai Formula in Patients with Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation: A Randomized Controlled Trial
    Yang Xiao-bing
    Chai Xiao-shu
    Wu Wan-yin
    Long Shun-qin
    Deng Hong
    Pan Zong-qi
    He Wen-feng
    Zhou Yu-shu
    Liao Gui-ya
    Xiao Shu-jing
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2018, 24 (10) : 734 - 740
  • [3] Gefitinib plus Fuzheng Kang'ai Formula(扶正抗癌方) in Patients with Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation:A Randomized Controlled Trial
    YANG Xiao-bing
    CHAI Xiao-shu
    WU Wan-yin
    LONG Shun-qin
    DENG Hong
    PAN Zong-qi
    HE Wen-feng
    ZHOU Yu-shu
    LIAO Gui-ya
    XIAO Shu-jing
    Chinese Journal of Integrative Medicine, 2018, 24 (10) : 734 - 740
  • [4] Gefitinib plus Fuzheng Kang’ai Formula (扶正抗癌方) in Patients with Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation: A Randomized Controlled Trial
    Xiao-bing Yang
    Xiao-shu Chai
    Wan-yin Wu
    Shun-qin Long
    Hong Deng
    Zong-qi Pan
    Wen-feng He
    Yu-shu Zhou
    Gui-ya Liao
    Shu-jing Xiao
    Chinese Journal of Integrative Medicine, 2018, 24 : 734 - 740
  • [5] Gefitinib Therapy in Patients With Advanced Non-Small Cell Lung Cancer With or Without Testing for Epidermal Growth Factor Receptor (EGFR) Mutations
    Wu, Jenn-Yu
    Shih, Jin-Yuan
    Chen, Kuan-Yu
    Yang, Chih-Hsin
    Yu, Chong-Jen
    Yang, Pan-Chyr
    MEDICINE, 2011, 90 (03) : 159 - 167
  • [6] Epidermal growth factor receptor mutations in patients with non-small cell lung cancer
    Johnson, BE
    Jänne, PA
    CANCER RESEARCH, 2005, 65 (17) : 7525 - 7529
  • [7] Epidermal growth factor receptor mutations are associated with gefitinib sensitivity in non-small cell lung cancer in Japanese
    Uramoto, H
    Sugio, K
    Oyama, T
    Ono, K
    Sugaya, M
    Yoshimatsu, T
    Hanagiri, T
    Morita, M
    Yasumoto, K
    LUNG CANCER, 2006, 51 (01) : 71 - 77
  • [8] A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations
    H Asahina
    K Yamazaki
    I Kinoshita
    N Sukoh
    M Harada
    H Yokouchi
    T Ishida
    S Ogura
    T Kojima
    Y Okamoto
    Y Fujita
    H Dosaka–Akita
    H Isobe
    M Nishimura
    British Journal of Cancer, 2006, 95 : 998 - 1004
  • [9] A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations
    Asahina, H.
    Yamazaki, K.
    Kinoshita, I.
    Sukoh, N.
    Harada, M.
    Yokouchi, H.
    Ishida, T.
    Ogura, S.
    Kojima, T.
    Okamoto, Y.
    Fujita, Y.
    Dosaka-Akita, H.
    Isobe, H.
    Nishimura, M.
    BRITISH JOURNAL OF CANCER, 2006, 95 (08) : 998 - 1004
  • [10] The effect of gefitinib in patients with postoperative recurrent non-small cell lung cancer harboring mutations of the epidermal growth factor receptor
    Ryo Ko
    Hirotsugu Kenmotsu
    Yasushi Hisamatsu
    Hiroaki Akamatsu
    Shota Omori
    Kazuhisa Nakashima
    Takuya Oyakawa
    Kazushige Wakuda
    Takehito Shukuya
    Akira Ono
    Hisao Imai
    Tetsuhiko Taira
    Tateaki Naito
    Haruyasu Murakami
    Keita Mori
    Masahiro Endo
    Yasuhisa Ohde
    Kazuhisa Takahashi
    Toshiaki Takahashi
    International Journal of Clinical Oncology, 2015, 20 : 668 - 673
12345